Inhibition of angiogenesis.

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06

Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A (1997) 3.23

Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci U S A (1994) 2.90

Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal (2009) 1.98

Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol Cancer Res (2008) 1.58

Molecular profiling of angiogenesis markers. Am J Pathol (2002) 1.57

Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res (2010) 1.42

Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol (1995) 1.23

Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J Clin Invest (1994) 1.21

Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia (2005) 1.18

Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. Radiology (2008) 1.17

Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach. Am J Pathol (2000) 1.13

ADAM9 is involved in pathological retinal neovascularization. Mol Cell Biol (2009) 1.09

Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res (2013) 1.07

Interferon-beta for treatment of rheumatoid arthritis? Arthritis Res (2002) 1.04

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol (2015) 0.97

Natural product inhibitors of ocular angiogenesis. Exp Eye Res (2014) 0.97

Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. J Cancer Res Clin Oncol (2004) 0.96

Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol (2013) 0.93

Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene (2012) 0.92

AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice. Oncol Rep (2012) 0.90

Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system. Mol Cell Neurosci (2006) 0.90

Antiangiogenic Steroids in Human Cancer Therapy. Evid Based Complement Alternat Med (2005) 0.87

A novel three-dimensional system to study interactions between endothelial cells and neural cells of the developing central nervous system. BMC Neurosci (2007) 0.86

Targeting Neovascularization in Ischemic Retinopathy: Recent Advances. Expert Rev Ophthalmol (2013) 0.84

Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base (2008) 0.83

Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads. BMC Cancer (2014) 0.83

Mifepristone improves chemo-radiation response in glioblastoma xenografts. Cancer Cell Int (2013) 0.79

Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship? Neuroradiology (2005) 0.78

Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Mol Med (1998) 0.78

A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin. Dose Response (2015) 0.77

Imaging of angiogenesis in cardiology. Eur J Nucl Med Mol Imaging (2007) 0.76

Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model. Clin Exp Metastasis (1999) 0.75

Role of oxygenation and vascularization in drug resistance. Cytotechnology (1998) 0.75

Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (1989) 7.30

The role of angiogenesis in tumor growth. Semin Cancer Biol (1992) 5.33

A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72

Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci (1998) 2.60

Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol (1992) 1.79

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun (1991) 1.67

Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer (1994) 1.60

Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng (1991) 1.24

Regulation of cytoskeletal mechanics and cell growth by myosin light chain phosphorylation. Am J Physiol (1998) 1.23

Heparin-binding angiogenesis factors: detection by immunological methods. Clin Physiol Biochem (1987) 0.98

Metabolism of tumor regression from angiogenesis inhibition: 31P magnetic resonance spectroscopy. Magn Reson Med (1989) 0.75

Music therapy: tune-up for mind and body. Sci Dig (1982) 0.75